H Q He - JoVE Visualize

Showing results (1-10 of 36) with videos related to

Pageof 4

Sort By:

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|September 16, 2025

[Strengthening vaccine wastage research to improve the quality of vaccine management]Y Wang, H Q He

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|November 26, 2023

[A systematic review in health economics research on the expansion of human papilloma virus vaccination population to men]Y Su, H Q He, Y Zhou, et al.

Plant Disease|February 13, 2019

First Report of Southern Blight on Canadian Goldenrod (Solidago canadensis) Caused by Sclerotium rolfsii in ChinaW Tang, Y Z Zhu, H Q He, et al.

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|July 25, 2021

[Immunogenicity and safety of concomitant inoculation of Measles and rubella combined live vaccine and Japanese encephalitis attenuated live vaccine]X W Tang, R Yan, Y Zhou, et al.

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|February 12, 2025

[Review of epidemic trend and immunization strategy of diphtheria]Y Hu, H Q He, Y Zhu, et al.

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|January 19, 2025

[Progress of varicella prevalence and immunization strategies in adolescents and adults]X H Qi, S H Zheng, Y Su, et al.

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|October 28, 2021

[Impact of emergencies on immunization program, risk assessment and response recommendations]H Q He, L Wang, J R Li, et al.

Zhonghua Yi Xue Za Zhi|December 22, 2025

[Introduction of WHO position paper on herpes zoster vaccines (2025 edition)]S T Xu, L Z Feng, X Guo, et al.

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|April 3, 2025

[Research progress on breakthrough cases of vaccine-preventable diseases]Y Su, Y Zhu, Y Zhou, et al.

Neoplasma|April 5, 2019

LncRNA SNHG20 promotes tumorigenesis and cancer stemness in glioblastoma via activating PI3K/Akt/mTOR signaling pathwayX F Gao, H Q He, X B Zhu, et al.

Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:

Pageof 4

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|September 16, 2025

[Strengthening vaccine wastage research to improve the quality of vaccine management]Y Wang, H Q He

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|November 26, 2023

[A systematic review in health economics research on the expansion of human papilloma virus vaccination population to men]Y Su, H Q He, Y Zhou, et al.

Plant Disease|February 13, 2019

First Report of Southern Blight on Canadian Goldenrod (Solidago canadensis) Caused by Sclerotium rolfsii in ChinaW Tang, Y Z Zhu, H Q He, et al.

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|July 25, 2021

[Immunogenicity and safety of concomitant inoculation of Measles and rubella combined live vaccine and Japanese encephalitis attenuated live vaccine]X W Tang, R Yan, Y Zhou, et al.

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|February 12, 2025

[Review of epidemic trend and immunization strategy of diphtheria]Y Hu, H Q He, Y Zhu, et al.

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|January 19, 2025

[Progress of varicella prevalence and immunization strategies in adolescents and adults]X H Qi, S H Zheng, Y Su, et al.

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|October 28, 2021

[Impact of emergencies on immunization program, risk assessment and response recommendations]H Q He, L Wang, J R Li, et al.

Zhonghua Yi Xue Za Zhi|December 22, 2025

[Introduction of WHO position paper on herpes zoster vaccines (2025 edition)]S T Xu, L Z Feng, X Guo, et al.

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|April 3, 2025

[Research progress on breakthrough cases of vaccine-preventable diseases]Y Su, Y Zhu, Y Zhou, et al.

Neoplasma|April 5, 2019

LncRNA SNHG20 promotes tumorigenesis and cancer stemness in glioblastoma via activating PI3K/Akt/mTOR signaling pathwayX F Gao, H Q He, X B Zhu, et al.

Pageof 4